GGHYX Holdings Information

GGHYX is a mutual fund with a total of 80 individual holdings. The top holdings are Eli Lilly and Company stock at 10.59%, Johnson & Johnson at 6.76%, UnitedHealth Group at 6.17%, Merck & Co. at 4.59%, and AbbVie at 4.03%.

Total Holdings

Top 10 Percentage

45.82%

Asset Class

Equity

Fund Category

Health

Assets

1.22B

Forward PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	10.59%	111,322
2	JNJ	Johnson & Johnson	6.76%	318,485
3	UNH	UnitedHealth Group Incorporated	6.17%	179,631
4	MRK	Merck & Co., Inc.	4.59%	425,626
5	ABBV	AbbVie Inc.	4.03%	193,684
6	GILD	Gilead Sciences, Inc.	3.63%	337,004
7	ARGX	argenx SE	2.99%	42,230
8	CVS	CVS Health Corporation	2.52%	291,313
9	WELL	Welltower Inc.	2.34%	120,441
10	BTSG	BrightSpring Health Services, Inc.	2.20%	444,597
11	RPRX	Royalty Pharma plc	2.13%	440,990
12	CAH	Cardinal Health, Inc.	2.10%	110,152
13	GH	Guardant Health, Inc.	2.04%	152,178
14	VRTX	Vertex Pharmaceuticals Incorporated	2.01%	50,958
15	AXSM	Axsome Therapeutics, Inc.	1.58%	87,700
16	EW	Edwards Lifesciences Corporation	1.56%	219,094
17	TRPXX	Invesco Shrt-Trm Inv Treasury Instl	1.56%	18,825,670
18	TMO	Thermo Fisher Scientific Inc.	1.55%	32,631
19	BBIO	BridgeBio Pharma, Inc.	1.43%	216,227
20	WAT	Waters Corporation	1.41%	45,153
21	IQV	IQVIA Holdings Inc.	1.32%	67,768
22	EBR: UCB	UCB SA	1.24%	58,259
23	LGND	Ligand Pharmaceuticals Incorporated	1.18%	49,408
24	PTGX	Protagonist Therapeutics, Inc.	1.18%	103,952
25	NTRA	Natera, Inc.	1.17%	52,670

Showing 25 of 80 holdings

Subscribe to see the full list

Activate Now

As of Jul 31, 2026